Naproxen treatment inhibits articular cartilage loss in a rat model of osteoarthritis

The effects of naproxen, a nonsteroidal anti-inflammatory drug (NSAID), on articular cartilage degeneration in female Sprague-Dawley rats was examined. Osteoarthritis (OA) was induced by destabilization of the medial meniscus (DMM) in each knee. Rats were treated with acetaminophen (60 mg/kg), naproxen (8 mg/kg), or 1% carboxymethylcellulose (placebo) by oral gavage twice daily for 3 weeks, beginning 2 weeks after surgery. OA severity was assessed by histological Osteoarthritis Research Society International (OARSI) scoring and by measuring proximal tibia cartilage depth using contrast enhanced mu CT (n = 6 per group) in specimens collected at 2, 5, and 7 weeks after surgery as well as on pristine knees. Medial cartilage OARSI scores from the DMM knees of naproxen-treated rats were statistically lower (i.e., better) than the medial cartilage OARSI scores from the DMM knees of placebo-treated rats at 5-weeks (8.7 +/- 3.6 vs. 13.2 +/- 2.4, p = 0.025) and 7-weeks (9.5 +/- 1.2 vs. 12.5 +/- 2.5, p = 0.024) after surgery. At 5 weeks after DMM surgery, medial articular cartilage depth in the proximal tibia specimens was significantly greater in the naproxen (1.78 +/- 0.26 mm, p = 0.005) and acetaminophen (1.94 +/- 0.12 mm, p < 0.001) treated rats as compared with placebo-treated rats (1.34 +/- 0.24 mm). However, at 7 weeks (2 weeks after drug withdrawal), medial articular cartilage depth for acetaminophen-treated rats (1.36 +/- 0.29 mm) was significantly reduced compared with specimens from the naproxen-treated rats (1.88 +/- 0.14 mm; p = 0.004). The results indicate that naproxen treatment reduced articular cartilage degradation in the rat DMM model during and after naproxen treatment.

Automated summary

The research showed that treatment with naproxen reduced articular cartilage degradation in the rat model of DMM, both during and after the treatment.